Literature DB >> 33784074

Chemical and Biochemical Reactivity of the Reduced Forms of Nicotinamide Riboside.

Mikhail V Makarov, Faisal Hayat, Briley Graves, Manoj Sonavane, Edward A Salter, Andrzej Wierzbicki, Natalie R Gassman, Marie E Migaud.   

Abstract

All life forms require nicotinamide adenine dinucleotide, NAD+, and its reduced form NADH. They are redox partners in hundreds of cellular enzymatic reactions. Changes in the intracellular levels of total NAD (NAD+ + NADH) and the (NAD+/NADH) ratio can cause cellular dysfunction. When not present in protein complexes, NADH and its phosphorylated form NADPH degrade through intricate mechanisms. Replenishment of a declining total NAD pool can be achieved with biosynthetic precursors that include one of the reduced forms of nicotinamide riboside (NR+), NRH. NRH, like NADH and NADPH, is prone to degradation via oxidation, hydration, and isomerization and, as such, is an excellent model compound to rationalize the nonenzymatic metabolism of NAD(P)H in a biological context. Here, we report on the stability of NRH and its propensity to isomerize and irreversibly degrade. We also report the preparation of two of its naturally occurring isomers, their chemical stability, their reactivity toward NRH-processing enzymes, and their cell-specific cytotoxicity. Furthermore, we identify a mechanism by which NRH degradation causes covalent peptide modifications, a process that could expose a novel type of NADH-protein modifications and correlate NADH accumulation with "protein aging." This work highlights the current limitations in detecting NADH's endogenous catabolites and in establishing the capacity for inducing cellular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33784074      PMCID: PMC8684594          DOI: 10.1021/acschembio.0c00757

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  49 in total

1.  Lactate dehydrogenase inhibitors in NADH preparations.

Authors:  S A Margolis; B F Howell; R Schaffer
Journal:  Clin Chem       Date:  1977-09       Impact factor: 8.327

2.  Potential coenzyme inhibitors. 3. Some reactions of substituted nicotinamide and dihydronicotinamide derivatives.

Authors:  A C Lovesey
Journal:  J Med Chem       Date:  1969-11       Impact factor: 7.446

3.  The NAD+/PARP1/SIRT1 Axis in Aging.

Authors:  Andrew R Mendelsohn; James W Larrick
Journal:  Rejuvenation Res       Date:  2017-06       Impact factor: 4.663

Review 4.  Modulating NAD+ metabolism, from bench to bedside.

Authors:  Elena Katsyuba; Johan Auwerx
Journal:  EMBO J       Date:  2017-08-07       Impact factor: 11.598

Review 5.  [The history of renalase from amine oxidase to a a-NAD(P)H-oxidase/anomerase].

Authors:  I S Severina; V I Fedchenko; A V Veselovsky; A E Medvedev
Journal:  Biomed Khim       Date:  2015 Nov-Dec

Review 6.  The NAD metabolome--a key determinant of cancer cell biology.

Authors:  Alberto Chiarugi; Christian Dölle; Roberta Felici; Mathias Ziegler
Journal:  Nat Rev Cancer       Date:  2012-09-28       Impact factor: 60.716

Review 7.  Enzymology of mammalian NAD metabolism in health and disease.

Authors:  Giulio Magni; Giuseppe Orsomando; Nadia Raffelli; Silverio Ruggieri
Journal:  Front Biosci       Date:  2008-05-01

8.  In vivo (31) P MRS assessment of intracellular NAD metabolites and NAD(+) /NADH redox state in human brain at 4 T.

Authors:  Ming Lu; Xiao-Hong Zhu; Wei Chen
Journal:  NMR Biomed       Date:  2016-06-03       Impact factor: 4.044

9.  A facile analytical method for reliable selectivity examination in cofactor NADH regeneration.

Authors:  Tony Saba; Joseph W H Burnett; Jianwei Li; Panagiotis N Kechagiopoulos; Xiaodong Wang
Journal:  Chem Commun (Camb)       Date:  2020-01-28       Impact factor: 6.222

10.  Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.

Authors:  Barbara Calamini; Bernard D Santarsiero; Jean A Boutin; Andrew D Mesecar
Journal:  Biochem J       Date:  2008-07-01       Impact factor: 3.857

View more
  2 in total

1.  The Unusual Cosubstrate Specificity of NQO2: Conservation Throughout the Amniotes and Implications for Cellular Function.

Authors:  Faiza Islam; Kevin K Leung; Matthew D Walker; Shahed Al Massri; Brian H Shilton
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

2.  Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD+ by Generating Dihydronicotinamide Riboside.

Authors:  Eleonora Ciarlo; Magali Joffraud; Faisal Hayat; Maria Pilar Giner; Judith Giroud-Gerbetant; Jose Luis Sanchez-Garcia; Marie Rumpler; Sofia Moco; Marie E Migaud; Carles Cantó
Journal:  Nutrients       Date:  2022-07-01       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.